Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more
Market Cap & Net Worth: Abbott India Limited (ABBOTINDIA)
Abbott India Limited (NSE:ABBOTINDIA) has a market capitalization of $6.55 Billion (₹567.04 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #5621 globally and #195 in its home market, demonstrating a -4.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Abbott India Limited's stock price ₹26685.00 by its total outstanding shares 21249302 (21.25 Million).
Abbott India Limited Market Cap History: 2015 to 2026
Abbott India Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.37 Billion to $6.55 Billion (17.27% CAGR).
Index Memberships
Abbott India Limited is a constituent of 8 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$58.09 Billion | 2.75% | #13 of 20 |
|
NIFTY100 EQUAL WEIGHT
NIFTY100EW
|
$734.02 Billion | 0.22% | #74 of 99 |
|
NIFTY 500
NIFTY500
|
$1.33 Trillion | 0.12% | #181 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$72.50 Billion | 2.21% | #14 of 20 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$342.17 Billion | 0.47% | #79 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.62 Billion | 0.30% | #105 of 400 |
|
NIFTY MNC
NIFTYMNC
|
$121.54 Billion | 1.32% | #15 of 30 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.39 Trillion | 0.12% | #180 of 750 |
Weight: Abbott India Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Abbott India Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Abbott India Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Abbott India Limited's market cap is 0.11 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.50x
Abbott India Limited's market cap is 0.50 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.09 Billion | $25.78 Billion | $2.55 Billion | 0.04x | 0.43x |
| 2017 | $1.28 Billion | $28.93 Billion | $2.77 Billion | 0.04x | 0.46x |
| 2018 | $1.75 Billion | $33.00 Billion | $4.01 Billion | 0.05x | 0.44x |
| 2019 | $3.06 Billion | $36.76 Billion | $4.50 Billion | 0.08x | 0.68x |
| 2020 | $3.71 Billion | $40.91 Billion | $5.93 Billion | 0.09x | 0.63x |
| 2021 | $4.62 Billion | $43.08 Billion | $6.91 Billion | 0.11x | 0.67x |
| 2022 | $5.10 Billion | $49.10 Billion | $7.99 Billion | 0.10x | 0.64x |
| 2023 | $5.53 Billion | $53.47 Billion | $9.49 Billion | 0.10x | 0.58x |
| 2024 | $7.30 Billion | $58.47 Billion | $12.01 Billion | 0.12x | 0.61x |
| 2025 | $7.12 Billion | $64.09 Billion | $14.14 Billion | 0.11x | 0.50x |
Competitor Companies of ABBOTINDIA by Market Capitalization
Companies near Abbott India Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Abbott India Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Abbott India Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Abbott India Limited's market cap moved from $1.37 Billion to $ 6.55 Billion, with a yearly change of 17.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹6.55 Billion | -8.06% |
| 2025 | ₹7.12 Billion | -2.41% |
| 2024 | ₹7.30 Billion | +32.03% |
| 2023 | ₹5.53 Billion | +8.44% |
| 2022 | ₹5.10 Billion | +10.35% |
| 2021 | ₹4.62 Billion | +24.42% |
| 2020 | ₹3.71 Billion | +21.36% |
| 2019 | ₹3.06 Billion | +75.20% |
| 2018 | ₹1.75 Billion | +36.14% |
| 2017 | ₹1.28 Billion | +18.10% |
| 2016 | ₹1.09 Billion | -20.86% |
| 2015 | ₹1.37 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Abbott India Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.55 Billion USD |
| MoneyControl | $6.55 Billion USD |
| MarketWatch | $6.55 Billion USD |
| marketcap.company | $6.55 Billion USD |
| Reuters | $6.55 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.